1. Home
  2. WST vs EME Comparison

WST vs EME Comparison

Compare WST & EME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • EME
  • Stock Information
  • Founded
  • WST 1923
  • EME 1987
  • Country
  • WST United States
  • EME United States
  • Employees
  • WST N/A
  • EME N/A
  • Industry
  • WST Medical/Dental Instruments
  • EME Engineering & Construction
  • Sector
  • WST Health Care
  • EME Industrials
  • Exchange
  • WST Nasdaq
  • EME Nasdaq
  • Market Cap
  • WST 15.6B
  • EME 21.2B
  • IPO Year
  • WST N/A
  • EME N/A
  • Fundamental
  • Price
  • WST $221.34
  • EME $541.60
  • Analyst Decision
  • WST Buy
  • EME Buy
  • Analyst Count
  • WST 7
  • EME 5
  • Target Price
  • WST $331.67
  • EME $501.60
  • AVG Volume (30 Days)
  • WST 693.0K
  • EME 460.3K
  • Earning Date
  • WST 07-24-2025
  • EME 07-24-2025
  • Dividend Yield
  • WST 0.38%
  • EME 0.18%
  • EPS Growth
  • WST N/A
  • EME 49.21
  • EPS
  • WST 6.37
  • EME 22.63
  • Revenue
  • WST $2,895,800,000.00
  • EME $15,001,212,000.00
  • Revenue This Year
  • WST $3.38
  • EME $14.10
  • Revenue Next Year
  • WST $5.85
  • EME $5.69
  • P/E Ratio
  • WST $34.66
  • EME $23.89
  • Revenue Growth
  • WST N/A
  • EME 14.30
  • 52 Week Low
  • WST $187.43
  • EME $319.49
  • 52 Week High
  • WST $352.33
  • EME $545.30
  • Technical
  • Relative Strength Index (RSI)
  • WST 54.22
  • EME 78.33
  • Support Level
  • WST $215.67
  • EME $516.91
  • Resistance Level
  • WST $226.80
  • EME $538.30
  • Average True Range (ATR)
  • WST 5.24
  • EME 11.38
  • MACD
  • WST -0.13
  • EME 4.08
  • Stochastic Oscillator
  • WST 58.92
  • EME 99.94

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About EME EMCOR Group Inc.

EMCOR Group Inc is a specialty contractor in the United States and a provider of electrical and mechanical construction and facilities services, building services, and industrial services. Its services are provided to a broad range of commercial, technology, manufacturing, industrial, healthcare, utility, and institutional customers through approximately 100 operating subsidiaries. The company's operating subsidiaries are organized into reportable segments: United States mechanical construction and facilities services, which derives key revenue; United States electrical construction and facilities services; United States building services; United States industrial services; and United Kingdom building services. Geographically, its key revenue is derived from the United States.

Share on Social Networks: